Intrinsiqq
ResMed Inc. logo

ResMed Inc.

RMD

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$33.10B
EPS$10.98
P/E21.43
P/FCF20.57
EV/EBITDA15.66
FCF Yield4.9%
Div. Yield1.08%
Net Debt/FCF-0.2x
ResMed Inc. intrinsic value
52-Week Range
$182.82$275.96

Profitability & Returns

Revenue (TTM)

$5.73B

▲ +9.9% YoY

Net Income (TTM)

$1.59B

▲ +8.8% YoY

Op. Margin

33.02%

▲ +0.6pp YoY

ROIC

20.71%

▼ -1.5pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$1.61B

▼ -0.7% YoY

Op. Cash Flow (TTM)

$1.77B

▲ +3.1% YoY

Net Debt

-$400M

Net Cash Position

Cash & Equiv.

$1.01B

5Y CAGR: +12.1%

5Y CAGR: +21.1%

Continue Research

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RMD

CompareIntrinsic value
DXCMDexCom, Inc.
$79.41-5.98%88
WSTWest Pharmaceutical Services, Inc.
$399.81+1.87%46
SOLVSolventum Corporation
$90.38+3.67%12
GMEDGlobus Medical Inc.
$71.05-12.76%72
MMEDMiniMed Group, Inc.
$16.71-7.98%25
PODDInsulet Corporation
$145.30-6.93%79
TFXTeleflex Incorporated
$150.87-0.84%31
ICUIIcu Medical Inc.
$172.11+2.66%46

Held by ETFs

RMD is in 303 US ETFs. The largest of them, with RMD's weight in each:

ResMed (RMD) in four numbers

Fair value (earnings)
$380.27
Price $235.30 is 38% below it.
Intrinsic Value
Quality score
91/100
Best check: cash flow growth, 29.4%. Weakest: revenue growth, 7.9%.
Quality
Dividend (TTM)
$2.46
1.08% yield, raised 5 years in a row.
Dividends
P/E
21.43
Price to free cash flow 20.57.
Financials

Questions about ResMed

Is ResMed (RMD) overvalued?

At $235.30, ResMed's price is 38% below the $380.27 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 21.43 times earnings and 20.57 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is ResMed's fair value?

Intrinsiqq's calculator puts ResMed's fair value at $380.27 a share. It grows earnings per share 18.2% a year for 5 years, applies an exit P/E of 23.2, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $285.21. Every input can be changed on the Intrinsic Value tab.

Is ResMed a high-quality business?

ResMed scores 91 out of 100 on Intrinsiqq's quality score, which makes it a high-quality business on these measures. The score blends 8 checks computed from SEC filings. Its best check is cash flow growth at 29.4%, and its weakest is revenue growth at 7.9%. The Quality tab shows every check against its target.

Does ResMed (RMD) pay a dividend, and how much?

Yes. ResMed (RMD) pays a dividend: $2.46 per share over the last twelve months, a dividend yield of 1.08% at the latest close. It has raised its dividend per share for 5 years in a row, growing at 9.0% a year over the last 5 years. The payout takes about 22.4% of earnings.

Source: 10-Q filed 26 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in RMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing RMD

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.